Format

Send to

Choose Destination
See comment in PubMed Commons below
Sci Transl Med. 2011 Aug 17;3(96):96ps35. doi: 10.1126/scitranslmed.3001512.

The emergence of genome-based drug repositioning.

Author information

1
Section of Genetic Medicine, University of Chicago, Chicago, IL 60637, USA. ylussier@medicine.bsd.uchicago.edu

Abstract

In a pair of papers in this issue of Science Translational Medicine, Butte et al. provide a concrete example of how reinterpreting and comparing genome-wide metrics allows us to effectively hypothesize which drugs from one disease-indication can be repurposed for another disease. The shift toward integrative genome-wide computational approaches has precedence in insightful scalar theories of biological information. Here, we discuss how this recent work in drug repurposing adheres to and takes advantage of the concepts surrounding this information paradigm.

PMID:
21849663
PMCID:
PMC4262402
DOI:
10.1126/scitranslmed.3001512
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center